Point72 Asset Management, L.P.

13F Holdings History for Amylyx Pharmaceuticals, Inc. - COMMON STOCK (AMLX)

Symbol: AMLX on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 4.72M shares
Security Ownership: 5.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Point72 Asset Management, L.P. ownership in Amylyx Pharmaceuticals, Inc. COMMON STOCK (AMLX)

2025-06-25 - Point72 Asset Management, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.72M shares of Amylyx Pharmaceuticals, Inc. COMMON STOCK (AMLX). This represents 5.3% percent ownership of the company. In their previous filing dated 2025-05-15, Point72 Asset Management, L.P. had reported owning 1.05M shares, indicating an increase of 350% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Point72 Asset Management, L.P.	5.3%	+410%	$24.3M	4.72M	+3,669,366	+350%	$5.15	13G	6/24/2025	25 Jun 2025 17:24:44
Point72 Asset Management, L.P.	1.2%	-73.3%	$3.66M	1.05M	-3,771,990	-78.3%	$3.49	13G/A	3/31/2025	15 May 2025 15:52:41
Point72 Asset Management, L.P.	5.6%		$16.8M	4.82M			$3.49	13G	1/13/2025	14 Jan 2025 16:53:24

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.07%	+0.05%	$29.1M	4.54M	+3,619,300	+395%	$6.41	Q2 2025
3/31/2025	0.01%	+0.01%	$3.25M	917K	+916,966	NEW	$3.54	Q1 2025
12/31/2024		0%	$0	0	-200	-100%		Q4 2024
9/30/2024	0%	+0%	$648	200	+200	NEW	$3.24	Q3 2024
6/30/2024		0%	$0	0	-170,000	-100%		Q2 2024
3/31/2024	0%	-0.02%	$483K	170K	-2,581,305	-93.8%	$2.84	Q1 2024
12/31/2023	0.12%	+0.12%	$40.5M	2.75M	+2,751,259	+5980998%	$14.72	Q4 2023
9/30/2023	0%	0%	$842	46	-7,061	-99.4%	$18.30	Q3 2023
6/30/2023	0%	-0.02%	$153K	7.11K	-317,693	-97.8%	$21.57	Q2 2023
3/31/2023	0.03%	-0.16%	$9.53M	325K	-1,803,160	-84.7%	$29.34	Q1 2023
12/31/2022	0.27%	+0.21%	$78.6M	2.13M	+1,660,999	+356%	$36.95	Q4 2022
9/30/2022	0.05%	+0.02%	$13.1M	467K	+154,500	+49.4%	$28.15	Q3 2022
6/30/2022	0.03%	+0.03%	$6.02M	312K	+312,461	NEW	$19.26	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.